Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Business Today.
Press releases published on August 11, 2025
TELA Bio Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
MALVERN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the second quarter ended …
Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 11, 2025
- FDA approval of IDE to conduct a U.S. pilot study exploring the use of Alpha DaRT in patients with recurrent glioblastoma multiforme (GBM), a highly aggressive brain cancer - - Multiple U.S. clinical trials, including pancreatic cancer and GBM pilot …
HighPeak Energy, Inc. Announces Second Quarter 2025 Financial and Operating Results
GlobeNewswire
·
August 11, 2025
FORT WORTH, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced financial and operating results for the quarter ended June 30, 2025. Second Quarter 2025 Highlights Sales volumes …
FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 11, 2025
Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $210 million, a $50 million increase from initial guidance Net cash held in China at closing now estimated to be approximately $125 million Transaction …
Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
August 11, 2025
Tividenofusp alfa BLA for Hunter syndrome accepted for priority review and assigned PDUFA target action date of January 5, 2026; company preparing for commercial launch DNL126 accelerated approval path for Sanfilippo syndrome Type A aligned with FDA; Phase …
Fluence Energy, Inc. Reports Third Quarter 2025 Results; Reaffirms Fiscal Year 2025 Guidance
GlobeNewswire
·
August 11, 2025
ARLINGTON, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its …
Mercury Systems Reports Fourth Quarter and Fiscal 2025 Results
GlobeNewswire
·
August 11, 2025
Record Q4 FY25 Bookings of $341.5 million; book-to-bill of 1.25 Record backlog of $1.40 billion; up 6% year-over-year Q4 FY25 Revenue of $273.1 million; GAAP net income of $16.4 million; and adjusted EBITDA of $51.3 million Q4 FY25 Operating Cash Flow of $ …
MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended June 30, 2025
GlobeNewswire
·
August 11, 2025
Results for the Quarter Ended June 30, 2025 and Other Recent Highlights: Net investment income per share for the quarter was $0.39, compared to $0.37 for the quarter ended March 31, 2025 Net asset value per share as of the end of the quarter was $14.75, …
Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 11, 2025
FDA accepts NDA submission for Anaphylm™; PDUFA date set for January 31, 2026 Planning continues for a Q1 2026 U.S. launch of Anaphylm, if approved by the FDA Company accelerates Anaphylm global expansion strategy to Canada and the EU Company to host …
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results
GlobeNewswire
·
August 11, 2025
Selected 90 mg once-daily palazestrant for Part 2 of the OPERA-01 Phase 3 monotherapy trial and for the OPERA-02 Phase 3 trial in combination with ribociclib OPERA-01 enrollment ongoing with top-line data expected in the second half of 2026; OPERA-02 on …
Rapid7 to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 11, 2025
BOSTON, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will be attending the following conferences: The Canaccord Genuity 45th Annual Growth Conference in …
USA Rare Earth Reports its Second Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
STILLWATER, Okla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (“USAR” or the “Company”) today announced its financial and operational results for the second quarter and six months ended June 30, 2025. Second Quarter Highlights …
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
Advancing Selection of Next-Generation Oral Small Molecule PTH1R Agonist for Clinical Development Initiating Phase 1 Trial for SEP-631, MRGPRX2 NAM Program, for Mast Cell Diseases Updated Cash Runway Expected to Support Operating Plans at Least into 2029 …
Gevo Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDA1 for the Second Quarter and Six Months Ended June 30, 2025 Positive Net Income Attributable to Gevo of $2.1 million in the Second Quarter Positive Adjusted EBITDA1 of $17 …
Xenon Reports Second Quarter 2025 Financial Results & Business Update
GlobeNewswire
·
August 11, 2025
– Phase 3 azetukalner X-TOLE2 FOS study patient recruitment complete, with topline data anticipated in early 2026 – Phase 3 azetukalner neuropsychiatric studies underway with X-NOVA3 in MDD and X-CEED in BPD recently initiated – Phase 1 healthy volunteer …
Plug Power Second Quarter 2025 Highlights
GlobeNewswire
·
August 11, 2025
• Execution on Project Quantum Leap helps accelerate business sales growth and financial performance • Q2 revenue up 21% year-over-year, driven by broad hydrogen demand LATHAM, N.Y., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a …
Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update
GlobeNewswire
·
August 11, 2025
Net income of $1.6 million and $5.3 million for the three and six months ended June 30, 2025, respectively; reaffirms full-year revenue guidance of $118-128 million Ping Zhang, Executive Chairman, appointed interim CEO as Dr. Han Ying transitions to …
Standard BioTools Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the second quarter ended June 30, 2025. Standard BioTools will no longer host …
Harrow Announces Second-Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
Second-Quarter 2025 and Recent Selected Highlights: Total revenues of $63.7 million, a 30% increase over $48.9 million recorded in the prior-year period GAAP net income of $5.0 million Adjusted EBITDA of $17.0 million Cash and cash equivalents of $53.0 …
Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 11, 2025
Daix (France), New York City (New York, United States), August 11, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment …